Patents by Inventor Maria Leia Smith

Maria Leia Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-MSLN BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240024502
    Abstract: The present disclosure provides anti-MSLN antibodies, antigen binding portions thereof and MSLN conjugates thereof for use in the treatment of cancer.
    Type: Application
    Filed: October 15, 2021
    Publication date: January 25, 2024
    Inventors: May Kung SUTHERLAND, Maria Leia SMITH
  • GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240024499
    Abstract: The present invention provides anti-GPC3 antibodies, antigen binding portions thereof and GPC3 conjugates thereof for use in the treatment of cancer.
    Type: Application
    Filed: November 19, 2021
    Publication date: January 25, 2024
    Inventors: Maria Leia SMITH, May Kung SUTHERLAND
  • HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
    Publication number: 20200165335
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: February 6, 2020
    Publication date: May 28, 2020
    Inventors: Maria Leia SMITH, Django SUSSMAN, William ARTHUR, Albina NESTEROVA
  • Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
    Publication number: 20180079810
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: August 31, 2017
    Publication date: March 22, 2018
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Humanized antibodies to LIV-1 and use of same to treat cancer
    Patent number: 9783608
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: October 10, 2017
    Assignee: SEATTLE GENETICS, INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
    Publication number: 20160185858
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: November 20, 2015
    Publication date: June 30, 2016
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive Cancers
    Publication number: 20160003847
    Abstract: The application provides methods of diagnosis, prognosis, prophylaxis and treatment of ovarian, pancreatic and other cancers using antibodies that specifically bind to denatured CD70.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 7, 2016
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Maureen Ryan, Maria Leia Smith
  • Humanized antibodies to LIV-1 and use of same to treat cancer
    Patent number: 9228026
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: January 5, 2016
    Assignee: SEATTLE GENETICS, INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Detection and treatment of pancreatic, ovarian and other cancers
    Patent number: 9120854
    Abstract: The application provides methods of diagnosis, prognosis, prophylaxis and treatment of ovarian, pancreatic and other cancers using antibodies that specifically bind to denatured CD70.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: September 1, 2015
    Assignee: SEATTLE GENETICS, INC.
    Inventors: Maureen Ryan, Maria Leia Smith
  • Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
    Publication number: 20130259860
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: December 6, 2011
    Publication date: October 3, 2013
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • DETECTION AND TREATMENT OF PANCREATIC, OVARIAN AND OTHER CANCERS
    Publication number: 20110300131
    Abstract: The application provides methods of diagnosis, prognosis, prophylaxis and treatment of ovarian, pancreatic and other cancers using antibodies that specifically bind to denatured CD70.
    Type: Application
    Filed: April 10, 2009
    Publication date: December 8, 2011
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Maureen Ryan, Maria Leia Smith
  • Humanized antibodies to LIV-1 and use of same to treat cancer
    Patent number: RE48959
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: March 8, 2022
    Assignee: SEAGEN INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova